Novel strategies of adoptive immunotherapy: How natural killer cells may change the treatment of elderly patients with acute myeloblastic leukemia

详细信息    查看全文

• 作者：Roberto M. Lemoli^a ; Sarah Parisi^b ; Antonio Curti^b ; ^{antonio.curti2@unibo.it}
• 刊名：Experimental Hematology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：45
• 期：Complete
• 页码：10-16
• 全文大小：666 K
• 卷排序：45

文摘

Alloreactive natural killer cells have been emerging as potent effector cells against acute myeloid leukemia. Several biological and immunologic issues still require full elucidation. The impact of donor natural killer alloreactivity is an important issue. Future trials on natural killer cells should correlate clinical results with donor alloreactive natural killer cell repertoire.